ABEONA THERAPEUTICS INC. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10QSB
144
25-NSE
3
4
4/A
424B1
424B3
424B4
424B5
425
8-A12B
8-A12G
8-K
8-K/A
ARS
AW
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DEFR14A
DEFS14A
EFFECT
NO ACT
NT 10-K
NT 10-Q
NTN 10Q
POS AM
PRE 14A
PRE 14C
PRER14A
PRES14A
PX14A6G
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-3/A
S-3DPOS
S-3MEF
S-4
S-4/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | — | 0001493152-20-016512 | Aug 21, 2020 | — |
| 4 | — | 0001493152-20-016305 | Aug 19, 2020 | Aug 17, 2020 |
| 8-K | — | 0001493152-20-015098 | Aug 10, 2020 | — |
| 10-Q | — | 0001493152-20-015077 | Aug 10, 2020 | Jun 30, 2020 |
| SC 13G | — | 0001172661-20-001460 | Jul 7, 2020 | — |
| 8-K | — | 0001493152-20-011653 | Jun 23, 2020 | Jun 17, 2020 |
| 3 | — | 0001493152-20-011507 | Jun 19, 2020 | Jun 17, 2020 |
| 4 | — | 0001493152-20-011508 | Jun 19, 2020 | Jun 17, 2020 |
| 3 | — | 0001493152-20-011505 | Jun 19, 2020 | Jun 17, 2020 |
| 4 | — | 0001493152-20-011509 | Jun 19, 2020 | Jun 17, 2020 |
| 4 | — | 0001493152-20-009768 | May 22, 2020 | May 20, 2020 |
| 4 | — | 0001493152-20-009764 | May 22, 2020 | May 20, 2020 |
| 4 | — | 0001493152-20-009770 | May 22, 2020 | May 20, 2020 |
| 4 | — | 0001493152-20-009756 | May 22, 2020 | May 20, 2020 |
| 4 | — | 0001493152-20-009758 | May 22, 2020 | May 20, 2020 |
| 4 | — | 0001493152-20-009760 | May 22, 2020 | May 20, 2020 |
| 4 | — | 0001493152-20-009762 | May 22, 2020 | May 20, 2020 |
| 4 | — | 0001493152-20-009766 | May 22, 2020 | May 20, 2020 |
| S-8 | — | 0001493152-20-009633 | May 21, 2020 | — |
| 8-K | — | 0001493152-20-009632 | May 21, 2020 | May 20, 2020 |
| 10-Q | — | 0001493152-20-007824 | May 6, 2020 | Mar 31, 2020 |
| 8-K | — | 0001493152-20-007832 | May 6, 2020 | — |
| PX14A6G | PX14A6G | 0001140361-20-010109 | Apr 29, 2020 | — |
| 8-K | — | 0001493152-20-007070 | Apr 24, 2020 | Apr 21, 2020 |
| DEFA14A | — | 0001493152-20-007004 | Apr 23, 2020 | — |
| SC 13D/A | SCHEDULE 13D (AMENDMENT NO. 1) | 0000914121-20-001562 | Apr 22, 2020 | — |
| 8-K | — | 0001493152-20-006853 | Apr 21, 2020 | Apr 15, 2020 |
| 3 | — | 0001493152-20-006766 | Apr 20, 2020 | Apr 15, 2020 |
| 4 | — | 0001493152-20-006669 | Apr 17, 2020 | Apr 15, 2020 |
| 3 | — | 0001493152-20-006668 | Apr 17, 2020 | Apr 15, 2020 |
| DEF 14A | DEF 14A | 0001140361-20-008572 | Apr 10, 2020 | May 20, 2020 |
| 8-K | — | 0001493152-20-005895 | Apr 6, 2020 | Mar 31, 2020 |
| 4 | — | 0001493152-20-004438 | Mar 20, 2020 | Mar 19, 2020 |
| 4 | — | 0001493152-20-004255 | Mar 18, 2020 | Mar 16, 2020 |
| 4 | — | 0001493152-20-004256 | Mar 18, 2020 | Mar 16, 2020 |
| 4 | — | 0001493152-20-004252 | Mar 18, 2020 | Mar 16, 2020 |
| 4 | — | 0001493152-20-004254 | Mar 18, 2020 | Mar 16, 2020 |
| 8-K | — | 0001493152-20-004028 | Mar 16, 2020 | — |
| 8-K | — | 0001493152-20-004018 | Mar 16, 2020 | Mar 10, 2020 |
| 10-K | — | 0001493152-20-004015 | Mar 16, 2020 | Dec 31, 2019 |
| SEC STAFF LETTER | — | 9999999997-20-000555 | Mar 6, 2020 | — |
| SEC STAFF LETTER | — | 9999999997-20-000759 | Feb 18, 2020 | — |
| SC 13G/A | — | 0000080255-20-001035 | Feb 14, 2020 | — |
| SC 13G/A | ABEONA THERAPEUTICS INC. | 0000902664-20-000948 | Feb 12, 2020 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-013396 | Feb 10, 2020 | — |
| SC 13G/A | — | 0001319244-20-000037 | Feb 6, 2020 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-20-000304 | Jan 28, 2020 | — |
| 8-K | — | 0001493152-20-000364 | Jan 8, 2020 | Jan 7, 2020 |
| 8-K | — | 0001493152-20-000323 | Jan 7, 2020 | Jan 2, 2020 |
| 4 | — | 0001493152-19-019948 | Dec 31, 2019 | Dec 24, 2019 |